Variation Biotechnologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Variation biotechnologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Variation Biotechnologies Today - Breaking & Trending Today

Vaccine-maker's Ottawa R&D efforts get boost thanks to millions in fresh funding

VBI Vaccines will immediately have access to up to $50 million (all terms U.S.) in cash, consisting of $30 million in refinanced funding as well as $20 million in new financing. ....

United States , United Kingdom , Jeff Baxter , National Research Council , Paulson Capital Corp , European Union , Hunt Club , Mississauga Based Resilience , Variation Biotechnologies , Paulson Capital ,

Vaccine-maker's Ottawa R&D efforts get boost thanks to millions in fresh funding

Vaccine-maker's Ottawa R&D efforts get boost thanks to millions in fresh funding
obj.ca - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from obj.ca Daily Mail and Mail on Sunday newspapers.

United States , United Kingdom , Jeff Baxter , National Research Council , Paulson Capital Corp , European Union , Hunt Club , Mississauga Based Resilience , Variation Biotechnologies , Paulson Capital ,

Biotech firm with major Ottawa footprint taps into US$12M in new financing


A vaccine-maker with a major Ottawa presence that is working on a locally developed COVID-19 jab as well as vaccines that target diseases such as cancer and hepatitis B is tapping into millions of dollars in new financing.
Massachusetts-based VBI Vaccines says it’s drawing a US$12-million tranche from a previously announced debt financing facility with K2 HealthVentures, a specialty finance company focused on the health-care sector. 
The firm has agreed to provide VBI with up to US$52 million to help the company conduct its research. 
VBI employs about 35 people in Ottawa, where it operates an R&D facility on Hunt Club Road. The company is partnering with the National Research Council to create its coronavirus vaccine, which is being manufactured by Mississauga-based Resilience Biotechnologies, and earlier this year it received a multimillion-dollar funding boost to work on a new version that will target more transmissible variants of the virus.  ....

United Kingdom , United States , National Research Council , Strategic Innovation Fund , Paulson Capital Corp , Hunt Club , Mississauga Based Resilience Biotechnologies , Variation Biotechnologies , Paulson Capital , ஒன்றுபட்டது கிஂக்டம் , ஒன்றுபட்டது மாநிலங்களில் , தேசிய ஆராய்ச்சி சபை , மூலோபாய கண்டுபிடிப்பு நிதி , பால்சன் மூலதனம் கார்ப் , வேட்டை சங்கம் , பால்சன் மூலதனம் ,